Windtree Therapeutics, Inc. is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. The company's proprietary technology platform includes a synthetic, peptide-containing surfactant that is structurally similar to endogenous pulmonary surfactant and novel drug-delivery technologies being developed to enable noninvasive administration of aerosolized KL4 surfactant. Windtree Therapeutics, Inc., formerly known as Discovery Laboratories Inc., is based in Warrington, Pennsylvania.
| Revenue (Most Recent Fiscal Year) | -- |
| Net Income (Most Recent Fiscal Year) | $-20.29M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | -- |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.08 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -- |
| Net Margin (Trailing 12 Months) | -- |
| Return on Equity (Trailing 12 Months) | -347.82% |
| Return on Assets (Trailing 12 Months) | -81.41% |
| Current Ratio (Most Recent Fiscal Quarter) | 0.23 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.23 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | -- |
| Book Value per Share (Most Recent Fiscal Quarter) | $10.17 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-20.91 |
| Earnings per Share (Most Recent Fiscal Year) | $-94.24 |
| Diluted Earnings per Share (Trailing 12 Months) | $-27.71 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology |
| Common Shares Outstanding | 0.59M |
| Free Float | 0.59M |
| Market Capitalization | $0.28M |
| Average Volume (Last 20 Days) | 0.86M |
| Beta (Past 60 Months) | 0.64 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 0.93% |
| Percentage Held By Institutions (Latest 13F Reports) | 29.33% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |